Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15508 | 28869506 | Int J Mol Sci | Critical Role of the Human ATP-Binding Cassette G1 Transporter in Cardiometabolic Diseases. | 2017 | Details |
| A15511 | 28868179 | World J Gastrointest Pathophysiol | Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients. | 2017 | Details |
| A15512 | 28868048 | Front Endocrinol (Lausanne) | Extracellular Vesicles from Adipose Tissue-A Potential Role in Obesity and Type 2 Diabetes? | 2017 | Details |
| A15514 | 28867186 | Biochem Biophys Res Commun | Dietary β-conglycinin prevents acute ethanol-induced fatty liver in mice. | 2017 | Details |
| A15520 | 28864376 | Am J Med Sci | Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15528 | 28859855 | Gastroenterology | Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis. | 2017 | Details |
| A15530 | 28859228 | Hepatology | Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. | 2017 | Details |
| A15533 | 28857485 | FEBS J | Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes. | 2017 | Details |
| A15535 | 28857208 | Aliment Pharmacol Ther | Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period. | 2017 | Details |
| A15539 | 28853202 | Liver Int | Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients. | 2017 | Details |
| A15542 | 28852205 | Int J Obes (Lond) | Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial. | 2017 | Details |
| A15545 | 28849786 | Nat Rev Endocrinol | SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. | 2017 | Details |
| A15547 | 28848738 | Front Cardiovasc Med | Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance. | 2017 | Details |
| A15548 | 28848168 | Horm Res Paediatr | Novel Insights in the Metabolic Syndrome in Childhood and Adolescence. | 2017 | Details |
| A15550 | 28847729 | Biochem Biophys Res Commun | Hepatic GDF15 is regulated by CHOP of the unfolded protein response and alleviates NAFLD progression in obese mice. | 2017 | Details |
| A15552 | 28846948 | Int J Surg Case Rep | Biopsy-proven progressive fatty liver disease nine months post mini-gastric bypass surgery: A case study. | 2017 | Details |
| A15553 | 28846061 | Metab Syndr Relat Disord | Obstetric Outcomes in Women with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15555 | 28845491 | Med Ultrason | Non-alcoholic fatty liver disease, bulb carotid intima-media thickness and obesity phenotypes: results of a prospective observational study. | 2017 | Details |
| A15565 | 28840809 | Microbiol Spectr | Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile. | 2017 | Details |
| A15566 | 28840806 | Microbiol Spectr | Microbiota, Liver Diseases, and Alcohol. | 2017 | Details |
| A15575 | 28838452 | Transplant Proc | Utilization of the Iliac Artery as Inflow in the Morbidly Obese During Orthotopic Liver Transplantation: A Case Report. | 2017 | Details |
| A15579 | 28834687 | Appl Physiol Nutr Metab | Weight loss enhances hepatic antioxidant status in a NAFLD model induced by high-fat diet. | 2017 | Details |
| A15581 | 28833326 | Hepatology | Projected increase in obesity and non-alcoholic-steatohepatitis-related liver transplantation waitlist additions in the United States. | 2018 | Details |
| A15582 | 28831172 | Sci Rep | Pioglitazone Enhances Cytosolic Lipolysis, β-oxidation and Autophagy to Ameliorate Hepatic Steatosis. | 2017 | Details |
| A15584 | 28829976 | Diabetes Res Clin Pract | Nation-wide trends in non-alcoholic steatohepatitis (NASH) in patients with and without diabetes between 2004-05 and 2014-15 in England. | 2017 | Details |
| A15588 | 28825992 | J Nutr Biochem | Effects of delta-tocotrienol on obesity-related adipocyte hypertrophy, inflammation and hepatic steatosis in high-fat-fed mice. | 2017 | Details |
| A15599 | 28821440 | Cell Signal | Apelin protects against liver X receptor-mediated steatosis through AMPK and PPARα in human and mouse hepatocytes. | 2017 | Details |
| A15601 | 28820393 | J Physiol Pharmacol | Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease. | 2017 | Details |
| A15611 | 28811651 | Int J Obes (Lond) | iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner. | 2017 | Details |
| A15614 | 28809804 | Nutrients | Type 1 Diabetes and Non-Alcoholic Fatty Liver Disease: When Should We Be Concerned? A Nationwide Study in Brazil. | 2017 | Details |
| A15617 | 28805745 | Children (Basel) | Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics. | 2017 | Details |
| A15620 | 28804947 | J Clin Periodontol | Periodontitis and Non-alcoholic Fatty Liver Disease, a population-based cohort investigation in the Study of Health in Pomerania. | 2017 | Details |
| A15621 | 28804621 | Biomed Rep | Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease. | 2017 | Details |
| A15624 | 28803504 | Expert Rev Clin Pharmacol | The pharmacological management of NAFLD in children and adolescents. | 2017 | Details |
| A15626 | 28802566 | Gastroenterology | Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15628 | 28802074 | Hepatology | Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance. | 2017 | Details |
| A15629 | 28802062 | Hepatology | Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. | 2017 | Details |
| A15633 | 28797988 | Turk J Gastroenterol | Effects of long-term synbiotic supplementation in addition to lifestyle changes in children with obesity-related non-alcoholic fatty liver disease. | 2017 | Details |
| A15635 | 28797077 | PLoS One | Gender difference in NASH susceptibility: Roles of hepatocyte Ikkβ and Sult1e1. | 2017 | Details |
| A15643 | 28791501 | J Gastroenterol | Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease. | 2017 | Details |
| A15652 | 28783409 | Int Rev Immunol | Host defenses against metabolic endotoxaemia and their impact on lipopolysaccharide detection. | 2017 | Details |
| A15666 | 28776154 | Obes Surg | Sleeve Gastrectomy After Liver Transplantation: Feasibility and Outcomes. | 2018 | Details |
| A15667 | 28776153 | Obes Surg | Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in Obesity. | 2018 | Details |
| A15669 | 28775179 | BMJ Open | Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model. | 2017 | Details |
| A15670 | 28775168 | Cancer Res | JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity. | 2017 | Details |
| A15677 | 28770225 | Biomed Res Int | PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway. | 2017 | Details |
| A15678 | 28768719 | FASEB J | The specialized proresolving lipid mediator maresin 1 protects hepatocytes from lipotoxic and hypoxia-induced endoplasmic reticulum stress. | 2017 | Details |
| A15680 | 28767558 | Ann Surg | Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial. | 2017 | Details |
| A15681 | 28767077 | Children (Basel) | Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15682 | 28763870 | Zhonghua Gan Zang Bing Za Zhi | [Effect of liraglutide in treatment of non-alcoholic fatty liver disease: mechanism of action and research advances]. | 2017 | Details |
| A15684 | 28761689 | BMJ Open Gastroenterol | Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review. | 2017 | Details |
| A15690 | 28759573 | PLoS One | Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis. | 2017 | Details |
| A15692 | 28758929 | Int J Mol Sci | Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. | 2017 | Details |
| A15694 | 28758096 | Ann Transl Med | Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. | 2017 | Details |
| A15698 | 28753963 | Nutrients | The Combined Intervention with Germinated Vigna radiata and Aerobic Interval Training Protocol Is an Effective Strategy for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Other Alterations Related to the Metabolic Syndrome in Zucker Rats. | 2017 | Details |
| A15699 | 28752920 | Liver Transpl | Outcome of liver transplantation in patients with prior bariatric surgery. | 2017 | Details |
| A15701 | 28752050 | Mol Metab | Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. | 2017 | Details |
| A15702 | 28751722 | Sci Rep | Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma. | 2017 | Details |
| A15704 | 28751453 | J Endocrinol | Maternal modifiers of the infant gut microbiota: metabolic consequences. | 2017 | Details |
| A15707 | 28751080 | Med Clin (Barc) | Non-alcoholic fatty liver disease: A poorly known pandemic. | 2017 | Details |
| A15709 | 28750503 | Clin Mol Hepatol | Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals. | 2017 | Details |
| A15710 | 28750085 | PLoS One | Orphan nuclear receptor ERRγ is a key regulator of human fibrinogen gene expression. | 2017 | Details |
| A15712 | 28749418 | Nutrients | The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study. | 2017 | Details |
| A15714 | 28748119 | J Adv Res | Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. | 2016 | Details |
| A15717 | 28745372 | Mol Biosyst | Systems-level organization of non-alcoholic fatty liver disease progression network. | 2017 | Details |
| A15718 | 28745025 | Obesity (Silver Spring) | Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction. | 2017 | Details |
| A15719 | 28745024 | Obesity (Silver Spring) | Diet Quality in Midadulthood Predicts Visceral Adiposity and Liver Fatness in Older Ages: The Multiethnic Cohort Study. | 2017 | Details |
| A15723 | 30603331 | Diabetol Int | Immune regulation of glucose and lipid metabolism. | 2017 | Details |
| A15728 | 28741239 | Obes Surg | Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features. | 2018 | Details |
| A15729 | 28740738 | Int J Hepatol | Shorter Leukocyte Telomere Length in Relation to Presumed Nonalcoholic Fatty Liver Disease in Mexican-American Men in NHANES 1999-2002. | 2017 | Details |
| A15732 | 28739572 | Mol Pharmacol | Altenusin, a Nonsteroidal Microbial Metabolite, Attenuates Nonalcoholic Fatty Liver Disease by Activating the Farnesoid X Receptor. | 2017 | Details |
| A15736 | 28737568 | J Pediatr Gastroenterol Nutr | Systematic Review: Nutrition and Physical Activity in the Management of Paediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15739 | 28734553 | Clin Nutr | Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trial. | 2017 | Details |
| A15747 | 28730729 | Pediatr Obes | Traffic-related air pollution associations with cytokeratin-18, a marker of hepatocellular apoptosis, in an overweight and obese paediatric population. | 2017 | Details |
| A15753 | 28727287 | Liver Int | Weighing the risks: Morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list. | 2017 | Details |
| A15759 | 28723568 | Cell Rep | Loss of Hepatic Mitochondrial Long-Chain Fatty Acid Oxidation Confers Resistance to Diet-Induced Obesity and Glucose Intolerance. | 2017 | Details |
| A15760 | 28723414 | Pharmacol Ther | Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. | 2017 | Details |
| A15767 | 28720429 | Pharmacol Ther | Stable isotope-based flux studies in nonalcoholic fatty liver disease. | 2017 | Details |
| A15770 | 28718838 | Nutrients | Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats. | 2017 | Details |
| A15775 | 28715286 | Scand J Clin Lab Invest | Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A15776 | 28714900 | Int J Mol Sci | A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15777 | 28714405 | Curr Pharm Des | Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter. | 2017 | Details |
| A15780 | 28712339 | Expert Rev Gastroenterol Hepatol | The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2017 | Details |
| A15781 | 28711683 | Biochimie | Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice. | 2017 | Details |
| A15784 | 28710554 | Obes Surg | Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A15795 | 28706189 | Sci Rep | Vertical sleeve gastrectomy reverses diet-induced gene-regulatory changes impacting lipid metabolism. | 2017 | Details |
| A15797 | 28705466 | Clin Nutr | Serum folic acid levels are associated with the presence and severity of liver steatosis in Chinese adults. | 2017 | Details |
| A15798 | 28705172 | BMC Endocr Disord | Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss. | 2017 | Details |
| A15804 | 30568543 | J Med Biochem | Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease. | 2017 | Details |
| A15807 | 28699612 | Indian Pediatr | Relationship Between Immune Parameters and Non-alcoholic Fatty Liver Disease in Obese Children. | 2017 | Details |
| A15808 | 28699503 | Curr Med Chem | Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach. | 2017 | Details |
| A15811 | 28698350 | BMJ Open | Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol. | 2017 | Details |
| A15812 | 28696785 | Arch Physiol Biochem | Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model. | 2017 | Details |
| A15820 | 28694246 | Eur J Endocrinol | MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease. | 2017 | Details |
| A15828 | 28691397 | Mol Nutr Food Res | Cyanidin-3-glucoside increases whole body energy metabolism by upregulating brown adipose tissue mitochondrial function. | 2017 | Details |
| A15829 | 28691342 | Mol Nutr Food Res | Dual function of Lactobacillus kefiri DH5 in preventing high-fat-diet-induced obesity: direct reduction of cholesterol and upregulation of PPAR-α in adipose tissue. | 2017 | Details |
| A15830 | 28691103 | J Clin Transl Res | Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. | 2017 | Details |
| A15835 | 28689548 | Ugeskr Laeger | [Non-alcoholic fatty liver disease in children and adolescents]. | 2017 | Details |
| A15836 | 28689378 | Postepy Biochem | The roles of annexins in vascular endothelium dysfunction accompanying diabetes mellitus type 2. | 2017 | Details |
| A15837 | 28688543 | Eur J Intern Med | Liver steatosis: The new epidemic of the Third Millennium. Benign liver state or silent killer? | 2017 | Details |